Welcome: Guest | Site Use Options | Register | Login |

Kadmon Corporation LLC

Kadmon Corporation LLC

Profile last edited on: 2/27/2018
450 East 29th Street 5th Floor
New York, NY 10016
  (212) 308-6000
Business Identifier: Therapeutic drugs for the treatment of oncology, immunology and infectious or neurodegenerative diseases
Public Profile:
Kadmon Holdings, Inc.,(NYSE:KDMN) is a biopharmaceutical company working in small molecules and biologics space for application in autoimmune and fibrotic, oncology, and genetic diseases. The company offers a portfolio of branded generic ribavirin products for chronic hepatitis C virus infection; and distributes products in various therapeutic areas, including those indicated for the management of rare diseases. The firm's lead product candidates include KD025, a rho-associated coiled-coil kinase2 inhibitor, which is in Phase II clinical studies for the treatment of autoimmune, fibrotic, and neurodegenerative diseases; Tesevatinib, an oral tyrosine kinase inhibitor that is in Phase II clinical studies for use in the treatment of non-small cell lung cancer and glioblastoma, as well as for treating autosomal dominant polycystic kidney disease; and KD034 that is used for the treatment of Wilson's disease, a genetic liver disease. Kadmon Holdings, Inc. has a strategic collaborations and license agreements with a wide range of entities foreign and domestic

 Synopsis: Awardee Business Condition
Year Founded First SBIR Year Date of Last Award
Employee Range VC funded? IP Holdings
Revenue Range Private/Public Exchange/Symbol :

Unlock access

To unlock access to all SBIR-STTR company Profiles, a FREE site registration is required. Click here to register or login if you already have an account

Smart Office Options


Is this YOUR Company?

Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached

Do you know about this Awardees?

Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920